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Summary
Congenital heart defects are a feature of several genetic haploinsufficiency syn-
dromes, often involving transcriptional regulators. One property of haploinsufficient
genes is their propensity for network interactions at the gene or protein level. In this
article we took advantage of an online dataset of high throughput screening of muta-
tions that are embryonic lethal in mice. Our aim was to identify new genes where the
loss of function caused cardiovascular phenotypes resembling the 22q11.2 deletion
syndrome models, that is, heterozygous and homozygous loss of Tbx1. One gene
with a potentially haploinsufficient phenotype was identified, Setd5, thought to be
involved in chromatin modification. We found murine Setd5 haploinsufficiency to be
associated with double outlet right ventricle and perimembranous ventricular septal
defect, although no genetic interaction with Tbx1 was detected. Conditional muta-
genesis revealed that Setd5 was required in cardiopharyngeal mesoderm for progres-
sion of the heart tube through the ballooning stage to create a four-chambered
heart.
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1 | INTRODUCTION
Syndromic congenital heart disease (CHD) encompasses several
haploinsufficiency conditions. Haploinsufficient genes may be pre-
sent at a “hub” of interacting networks (Huang, Lee, Marcotte, &
Hurles, 2010), and phenotypic similarity has been used in human
genetics to cluster syndromes based on the premise that these
groupings inform biological relationships of the genes involved
that is, the underlying genes may function within the same devel-
opmental “module” (Oti & Brunner, 2007). The candidate gene for
22q11.2 deletion syndrome (22q11DS) is TBX1, and is
haploinsufficient in mice (Jerome & Papaioannou, 2001; Merscher
et al., 2001). In mice, Tbx1 heterozygotes present with hypo- or
aplasia of the fourth PAA at embryonic day (E)10.5 which gives rise
to great vessel defects such as interrupted aortic arch type B and
aberrant right subclavian artery at later stages. Other cardiovascu-
lar defects include double outlet right ventricle (DORV) and ven-
tricular septal defect (VSD) (Lindsay et al., 2001; Merscher
et al., 2001).
An initiative entitled Deciphering the Mechanisms of Develop-
mental Disorders (DMDD) aimed to take advantage of embryonic
lethal mouse lines containing insertions that initially offer a gene-
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trap-like reporter allele with heterozygous or hypomorphic effect
(https://dmdd.org.uk/; Mohun et al., 2013). Upon Flpe recombina-
tion, this converts to a conditional allele offering the potential for
tissue-specific studies of heart and brain development. Thus, the
DMDD browser provides an online database of mutants where
standard phenotype ontology terms can be used to search for genes
with phenotypes related to known birth defect syndromes. The
database contains high-resolution episcopic microscopic (HREM)
images of embryos at E9.5 and E14.5 allowing local rephenotyping.
The database contained 209 genes analysed at E9.5 and E14.5.
Querying the online browser with key phenotype ontology terms
that define the Tbx1 haploinsufficient phenotype such as “DORV”
and “VSD” generated a list of genes that caused these defects
when mutated. Out of the 209 total genes, a mutation in only a sin-
gle gene caused DORV and VSD when heterozygous: Setd5 (MGI
allele: 4432631). We concluded Setd5 was a strong candidate for
causing haploinsufficient cardiac defects that are similar to those
observed due to Tbx1 haploinsufficiency. Moreover, there was a
severe loss of function, lethal phenotype in Setd5 nulls (https://
dmdd.org.uk/).
Setd5, a ubiquitously expressed gene (Osipovich, Gangula, Vianna, &
Magnuson, 2016), is thought to act as a histone modifier. Unlike other
SET-domain proteins, SETD5 appears to lack histone methyltransferase
activity (Deliu et al., 2018; Osipovich et al., 2016). Immunoprecipitation
and mass spectrometry studies indicate SETD5 associated with HDAC3,
a protein complex containing histone-deacetylating activity; however,
there is conflicting evidence on whether SETD5 is required for
HDAC3 recruitment (Deliu et al., 2018; Nakagawa et al., 2020;
Osipovich et al., 2016). Clinical reports reveal the implications of
SETD5 haploinsufficiency in human intellectual disability, with some
patients presenting with cardiac abnormalities (Fernandes et al., 2018;
Grozeva et al., 2014; Szczałuba et al., 2016). Furthermore, CHD is
present in up to 50% of patients with deleterious mutations in chro-
matin modification proteins underlying neurodevelopmental or
psychiatric syndromes (Zaidi & Brueckner, 2017). Despite this, the
role of Setd5 in cardiac development has not been extensively
investigated.
Osipovich et al showed that mice lacking Setd5 (MGI allele:
5576778) die before E10.5 and were developmentally delayed;
embryos were severely underdeveloped with many presenting
with hemorrhaging compared to littermate heterozygous controls
(Osipovich et al., 2016). Interestingly, unlike the heterozygous
embryos presented in the DMDD browser, Osipovich et al
reported heterozygous mice as viable and indistinguishable from
the wild-type embryos. Furthermore, the embryonic lethality of
Setd5 nulls by E10.5 limits the full assessment of the cardiac phe-
notype. The purpose of our study was, primarily, to more fully
delineate the cardiac phenotype caused by the disruption of
Setd5 expression, and secondarily to explore whether there was
any genetic interaction between Setd5 and Tbx1. Currently,
attempts to understand the Setd5 function are focused on neuro-
nal contexts; here we show the importance of this protein during
heart development.
2 | MATERIALS AND METHODS
2.1 | Mouse strains, breeding, and genotyping
All animal husbandry, maintenance, and procedures were carried out
in accordance to the UK Home Office regulations. All mice were
maintained on the C57Bl/6 background.
The Setd5Fl/Fl line was derived from the targeted mouse line
(Setd5tm1a[EUCOMM]Wtsi MGI:4432631) (Wellcome Trust Sanger Insti-
tute) and kindly donated by the Basson laboratory (KCL). Setd5 heterozy-
gotes were generated by crossing the floxed line with mice expressing Actin-
Cre (Lewandoski, Meyers, & Martin, 1997). F1 mice harboring the Actin-Cre
were backcrossed with wild-type mice in order to generate mice without the
Actin-Cre for use in downstream experiments. Generation of double hetero-
zygotes involved breeding Setd5+/ with Tbx1lacZ/+ heterozygotes, described
previously (Lindsay et al., 2001). To generate Tbx1-cKOs, Setd5Fl/Fl mice were
crossed with Tbx1Cre/+ heterozygous mice, described previously (Huynh,
Chen, Terrell, & Baldini, 2007). To delete Setd5 in the cardiopharyngeal
mesoderm, Setd5Fl/Fl mice were bred with mice expressing Mesp1-Cre,
described previously (Saga et al., 1999). Timed matings for embryo collection
involved pairing sexually mature mice overnight and checking the presence
of a copulation plug the following morning, which indicated 0.5 days post
copulation. The PCR strategies for genotyping are available upon request.
2.2 | Tissue processing, whole-mount analysis, and
histological analysis
Whole embryos were fixed in 4% paraformaldehyde overnight at 4C
and then stored in PBS until required. For histological analyzes, whole
embryos or hearts were dehydrated in ethanol, and then processed in
Histoclear and several washes in wax. Samples were embedded in par-
affin and cut into 10 μm sections, air-dried overnight and then
rehydrated through a decreasing gradient of ethanol and stained with
hemotoxylin and eosin. Whole-mount embryo pictures were taken
using the Zeiss Lumar V12 Stereoscope. Histological sections were
imaged using the Zeiss Axioplan or the slide scanning facility at UCL
IQPath. Stage-matching was performed by assessment of the limb
buds and pharyngeal arches (Boehm et al., 2011; Musy et al., 2018).
2.3 | Calculation of double heterozygote expected
frequencies
In the absence of a synergistic genetic interaction, the expected fre-
quency of defects in a double heterozygote in which two genes of
interest are haploinsufficient is calculated as follows:
(A + B[1 – A])*n.
A = percentage of defects observed in one single heterozygote.
B = percentage of defects observed in alternate single
heterozygote. n = total number of double heterozygotes collected.
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Taking the example of VSDs presented in Table 1,
A = 75% = 0.75; B = 31% = 0.31; n = 14.
(0.75 + 0.31[1–0.75])* 14 = 12.
2.4 | Statistical analysis
To determine whether genetically modified mice or embryos pres-
ented at Mendelian ratios, Chi-squared analysis was performed. To
determine the association of genotype with the frequency of defects
observed, Fisher's exact test was performed. A p value less than .05
was taken to be significant.
3 | RESULTS
3.1 | Setd5 haploinsufficiency leads to outflow
tract rotational defects and VSDs
Setd5Fl/Fl mice were derived from the targeted mouse line (Setd5tm1a
[EUCOMM]Wtsi). The floxed line was then bred with Tmem163Tg(ACTB-
cre)2Mrt (Actin-Cre) mice in order to generate Setd5 heterozygotes
(Setd5 +/) for use in downstream embryo experiments. At E14.5,
normal heart development results in the septation of the outflow
tract (OFT) into the pulmonary trunk and aorta, with an intact inter-
ventricular septum dividing the left and right ventricles. A rotational
defect, such as DORV or overriding aorta, occurs when the OFT fails
to align with the two future ventricles at the looping stage. Correct
looping of the heart tube is necessary to align the two definitive
outflow vessels with their corresponding ventricular chambers
(Christoffels et al., 2000; Moorman & Christoffels, 2003). If the OFT
is misaligned such that an abnormal amount of aortic blood origi-
nates from the right ventricle, then this is known as an overriding
aorta. If more than 50% of the aortic blood arises from the right ven-
tricle, the result is DORV (Creazzo, Godt, Leatherbury, Conway, &
Kirby, 1998).
We found that wild-type hearts displayed correctly OFT septation
with the outflow vessels originating from separate ventricles
(Figure 1a‑a000). In contrast, despite correct OFT septation, 50% of
Setd5 heterozygotes presented with rotational defects which included
DORV or overriding aorta (Figure 1b‑b000) (p < .05, Fisher's exact test,
Table 1). DORV is always accompanied by a VSD, since the fusion of
the interventricular septum with the OFT cushions is necessary to
complete ventricular septation. If the outflow vessels of the OFT are
misaligned with the ventricular chambers, as in DORV, then this
fusion cannot take place which leads to a perimembranous VSD
(Anderson, 2003; Lin, Lin, Chen, Zhou, & Chang, 2012). Figure 1b00 00
shows a perimembranous VSD, which was observed in 75% of Setd5
heterozygotes (p < .05, Fisher's exact test, Table 1).
Therefore, in alignment with the DMDD browser, our results show
that Setd5 haploinsufficiency causes OFT rotation defects and VSDs.
3.2 | No detectable genetic interaction between
Setd5 and Tbx1, a well-established
haploinsufficient gene
Because some of the phenotypes observed in Setd5 heterozygotes over-
lap with those observed in Tbx1 heterozygotes, the genetic interaction
between Setd5 and Tbx1was investigated by generating double heterozy-
gotes, in which both genes of interest are haploinsufficient. Setd5 hetero-
zygotes were mated with Tbx1lacZ/+ heterozygotes (Tbx1tm1Bld) and
embryos were harvested at E14.5. An exacerbation of defects, that is, an
increased frequency of defects over that expected by additive effects, or
an increase in severity of defects, would be observed in the double het-
erozygotes in the case of synergistic genetic interaction.
There was no difference in the number of embryos at E14.5 based
on the genotypes (Table STable 1, Chi-squared, p > .05). Gross morpho-
logical analysis during embryo dissection and internal assessment by
histological methods revealed no exacerbation or increased frequency
of defects in double heterozygotes, suggesting that there was no
detectable synergistic genetic interaction between Setd5 and Tbx1 and
that these two genes are not functionally interdependent (Table 1).
TABLE 1 Summary of heart defects observed in WT, Setd5 heterozygotes (Setd5 +/), Tbx1 heterozygotes (Tbx1lacZ/+) and double
heterozygotes (Setd5+/; Tbx1lacZ/+) at E14.5
H&E analysis
WT(n = 8) Setd5+/ (n = 12) Tbx1lacZ/+ (n = 13)
Setd5+/; Tbx1lacZ/+ (n = 14)
Observed Expected n number
CAT 0 0 0 0 0
Rotational defects 0 6 (50%)* 1 (8%) 8 (57%) 8
VSD 1 (13%) 9 (75%)* 4 (31%) 12 (86%) 12
Great vessel defects
AbRS 0 0 1 (8%) 3 (21%) 1
Note: A Fisher's exact test was performed to determine whether the defects observed in Setd5 +/ were statistically significant compared to wild-type
control embryos (*p < .05 compared with WT). The expected frequency of defects in double heterozygotes (Setd5+/; Tbx1lacZ/+) was calculated as
described in the methods. Rotational defects encompass both double outlet right ventricle and overriding aorta.
Abbreviations: AbRS, aberrant right subclavian artery; CAT, common arterial trunk; VSD, ventricular septal defect.
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3.3 | Conditional mutagenesis of Setd5 reveals a
role in cardiogenic mesoderm
Our results show that the haploinsufficiency of Setd5 led to rotational
defects and VSD. These defects are reminiscent of the second heart
field (SHF)-specific defects seen in Tbx1 mutants. To investigate
whether Setd5 has a specific role in the SHF, and/or pharyngeal epi-
thelia, Setd5 was deleted using a Tbx1-Cre driver known to be active
in these tissues (Huynh et al., 2007). Figure 2 presents the gross mor-
phology of control and several Tbx1 conditional knockout (Tbx1-cKO)
F IGURE 1 Rotational defects,
including DORV was observed in
50% of Setd5 heterozygotes
(Setd5+/) and VSD were observed
in 75% of Setd5+/ embryos at
E14.5. In the WT heart, the
pulmonary trunk and aorta open into
separate ventricles: the right and left
ventricle, respectively (a‑a000). In
Setd5+/ hearts, DORV was
observed. In panel B0 the aorta and
pulmonary trunk are juxtaposed, and
in posterior sections b000, the aorta
eventually opens into the right
ventricle; both the pulmonary trunk
and aorta open into the right
ventricle. A perimembranous VSD is
observed in Setd5+/ (panel b00 00). Ao,
aorta; DORV, double outlet right
ventricle; LA, left atrium; LV, left
ventricle; PT, pulmonary trunk; RA,
right atrium; RV, right ventricle; VSD,
ventricular septal defects; WT, wild-
type. Scale bars = 400 μm
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hearts at E15.5. Minor abnormalities such as retroesophageal right
subclavian artery were observed (one in both Tbx1 conditional hetero-
zygote and knockout); this was likely due to the effect of the Cre
knock-in to the Tbx1 locus. Similarly, assessment of internal heart
morphology revealed no obvious differences between the genotypes
(Figure SFigure 1). Therefore, we concluded Setd5 likely exerts its role
earlier during cardiac development, or in other lineages, or both.
Indeed, the DMDD browser revealed an embryonic lethality of
homozygous Setd5 mutation (no surviving embryos at E14.5), and
Osipovich et al., showed that mice constitutively null for Setd5 die
before E10.5, and are severely underdeveloped. Hearts at E9.5 were
swollen with a single ventricular chamber (Osipovich et al., 2016). The
embryonic lethality of Setd5 constitutive null embryos by E10.5 limits
analysis of the importance of Setd5 in cardiac development. Lineage
tracing experiments show that the majority of cardiac cells are derived
from Mesp1-expressing progenitor cells (Saga et al., 1999). Therefore,
we used the Mesp1-Cre driver to delete Setd5 in mesoderm
encompassing both the first heart field (FHF) and SHF, as well as the
F IGURE 2 No obvious heart
malformations were observed
when Setd5 was homozygously
deleted using the Tbx1-Cre at
E15.5. No great vessel defects
were observed across the
genotypes (n = 19 conditional
mutants analysed). AA, aortic
arch; LA, left atria; LCC, left
common carotid; LSA, left
subclavian artery; LV, left
ventricle; RA, right atria; RCC,
right common carotid; RSA, right
subclavian artery; RV, right
ventricle; T, thymus. Scale
bars = 1 mm
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pharyngeal mesoderm through which the (non-Mesp1-expressing)
neural crest migrates. Homozygous deletion in this cardiopharyngeal
mesoderm lineage led to embryonic lethality before E12.5. At E10.5,
Mesp1-cKO embryos were harvested at the expected Mendelian ratio
(Table S2) but exhibited varying degrees of abnormal cardiac morpho-
genesis compared to stage-matched control embryos (p < .05,
Table 2). 90% of Mesp1-cKOs displayed abnormal cardiac chamber
ballooning, with 25% of these exhibiting a dumbbell-shaped heart
(Figure 3b), while others displayed right ventricular hypoplasia and
abnormal atrial ballooning (p < .05, Figure 3d). We assessed the inter-
nal heart morphology by histological techniques and found that 100%
of Mesp1-cKO embryos presented with a short OFT, indistinct ven-
tricular chambers, and poorly developed atria, revealing the impor-
tance of Setd5 in OFT elongation and cardiac chamber ballooning
(Figure 4). These defects were accompanied by a statistically signifi-
cant growth delay, determined by the crown-to-rump length (p < .05,
Figure SFigure 2). The OFT length was further assessed by quantifying
the number of paraffin sections containing the OFT and expressing
this as a ratio to the crown-to-rump length, confirming the shorter
OFT in Mesp1-cKO compared to control embryos (Figure SFigure 3).
Morphological analysis of Mesp1-Cre conditional heterozygotes
(n = 6) did not reveal any OFT phenotype, and histological analysis
revealed only a single embryo as having poorly developed cardiac
chambers.
4 | DISCUSSION
Our results indicate that haploinsufficiency of Setd5, a gene impli-
cated in human intellectual disability (Fernandes et al., 2018;
Grozeva et al., 2014; Szczałuba et al., 2016) with reported histone-
modifying activity (Deliu et al., 2018; Nakagawa et al., 2020;
Osipovich et al., 2016), leads to cardiac defects in mice. It is worth
noting that only one Mesp1-Cre conditional heterozygote presented
with poorly developed cardiac chambers. The remaining embryos
exhibited normal cardiac morphology, highlighting the fact that
deleting one allele of Setd5 in the Mesp1 lineage does not fully reca-
pitulate the global heterozygotes and that haploinsufficiency of
Setd5 requires constitutive heterozygosity. Since haploinsufficient
genes exist in hubs or networks and are more likely to interact with
other haploinsufficient genes (Huang et al., 2010), and because
haploinsufficiency of Setd5, and of Tbx1 lead to similar cardiac
defects, one of our initial aims were to investigate their genetic
interaction. However, our findings did not reveal a detectable syner-
gistic genetic interaction, suggesting that Setd5 and Tbx1 are not
functionally interdependent. Nevertheless, homozygous deletion of
Setd5 in the cardiopharyngeal mesoderm revealed a novel role of
Setd5 in cardiac development: its importance in OFT elongation and
cardiac chamber ballooning.
In humans, loss of function mutations in SETD5 lead to moderate
or severe intellectual disability (Fernandes et al., 2018; Grozeva
et al., 2014; Powis et al., 2018; Rawlins, Stals, Eason, &
Turnpenny, 2017; Szczałuba et al., 2016). It is also one of three genes
within the candidate region of 3p25 microdeletion syndrome which is
characterized by developmental delay, intellectual disability, low birth
weight, microcephaly and craniofacial abnormalities, and some obser-
vations of CHD (Grozeva et al., 2014; Kuechler et al., 2015; Szczałuba
et al., 2016). Mutations of SETD5 have been reported in other condi-
tions. For instance, one deletion and two mutations were described in
patients clinically diagnosed with KBG syndrome without a mutation
in ANKRD11, which is usually observed in these cases (OMIM
148050). One such patient presented with mitral stenosis (Crippa
et al., 2020). Interestingly, ANKRD11 recruits HDACs and is mutated
in autism (Gallagher et al., 2015). Recently, SETD5 has been implicated
in moyamoya angiopathy, which is the occlusion of large cerebral
arteries leading to childhood stroke (Pinard et al., 2020). Our results
TABLE 2 Summary of defects observed in Setd5Fl/Fl, Setd5Fl/WT, Setd5Fl/WT; Mesp1Cre/+, and Setd5Fl/Fl; Mesp1Cre/+ embryos at E10.5
Abnormal external morphology





Hemorrhage 0 0 0 3 (16%)
Pericardial effusion* 0 3 (13%) 0 14 (74%)
Abnormal cardiac chamber ballooning* 0 0 0 18 (95%)
H&E analysis




Short OFT* 0 0 0 6 (100%)
Abnormal ventricular ballooning* 0 0 1 (17%) 6 (100%)
Abnormal atrial ballooning* 0 0 0 6 (100%)
Note: The upper part of the table describes the defects observed during the dissection stage. The abnormal external cardiac morphology was further
delineated by sectioning and H&E analysis. Fisher's exact test was used to determine the association between the genotype and the frequency of any
defects observed.
*p < .05.
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reveal that Setd5, a gene implicated in neurodevelopmental disorders,
is also important in cardiac development, and may provide some
explanation to the clinical observations of CHD when SETD5 is
haploinsufficient in humans. Taken together, these data suggest con-
siderable pleiotropy of SETD5 function.
The genetic underpinnings of CHD remain unknown in over 50%
of cases, highlighting the importance of identifying novel genes that
may be involved in orchestrating cardiac development. Furthermore,
genome sequencing CHD studies present an overrepresentation of
genes involved in neurodevelopmental disorder (Sigmon, Kelleman,




pericardial effusion at E10.5. At
E10.5, Mesp1-cKO embryos
presented with abnormal cardiac
morphogenesis in 90% of the
cases with 25% of these
exhibiting a dumbbell shaped
heart: a single atria and single
ventricle (b,b0) compared with
control embryos (Setd5Fl/Fl or
Setd5Fl/WT). Pericardial effusion
was observed in 70% of Mesp1-
cKO embryos (red arrow, b0).
(d,d0) show a Mesp1-cKO embryo
with a short outflow tract, right
ventricular hypoplasia, and
abnormal atrial ballooning (red
arrow). A, atrium; LA, left atrium;
LV, left ventricle; lb, limb bud;
OFT, outflow tract; PE,
pericardial effusion; PAA,
pharyngeal arch artery. Scale
bars = 1 mm
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Susi, Nylund, & Oster, 2019; Watkins et al., 2019). As such, screening
for mutations in SETD5 during genetic testing could potentially pro-
vide some knowledge to families to better understand if there could
be recurrent risks of CHD to other family members, or provide infor-
mation for neurodevelopmental outcome.
Thus, our results provide the basis for further exploration of Setd5
in cardiac development. It will be interesting to investigate how this
histone modifier plays a role in orchestrating cardiac development in
conjunction with other known cardiac-relevant genes. Setd5 can now
be placed within a growing number of genes encoding chromatin
modifiers whose alleles are associated with both neurodevelopmental
defects on the one hand, and heart dysmorphogenesis on the other.
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